Kubota, G. T. It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine. Thieme Revinter Publicações.
Chicago Style (17th ed.) CitationKubota, Gabriel Taricani. It Is Time Anti-CGRP Monoclonal Antibodies Be Considered First-line Prophylaxis for Migraine. Thieme Revinter Publicações.
MLA (9th ed.) CitationKubota, Gabriel Taricani. It Is Time Anti-CGRP Monoclonal Antibodies Be Considered First-line Prophylaxis for Migraine. Thieme Revinter Publicações.
Warning: These citations may not always be 100% accurate.